業績一覧│大阪大学大学院医学系研究科保健学専攻生体物理工学講座放射線治療生物学研究室

2024年＋

1.	Ju M, Minami K, Katsuki S, Takenaka W, Tatekawa S, Tamari K, Koizumi M, Takahashi Y, Ogawa K. Synergistic Effects of Melatonin on Radiosensitization in Carbon-ion Radiotherapy. Anticancer Res. 2024 Aug;44(8):3295-3306. doi: 10.21873/anticanres.17148. PMID: 39060064.

2023年＋

1.	Inui S, Takahashi Y, Ueda Y, Ohira S, Washio H, Ono S, Miyazaki M, Nishio T, Koizumi M, Konishi K. Dosimetric Comparison of Helical Tomotherapy and HyperArc Treatment Plans for Angiosarcoma of the Scalp. Anticancer Res. 2023;43(7):3079-3087.
2.	Manabe Y, Takahashi Y (Equal contribution), Sugie C, Wang Z, Katsuki S, Kondo T, Murai T, Nakashima M, Takaoka T, Ogawa K, Shibamoto Y. Biological effects of prostaglandin E2-EP4 antagonist (AAT-008) in murine colon cancer in vivo: enhancement of immune response to radiotherapy and potential as a radiosensitizer. Transl Cancer Res 2023; 12(2):351－358.

2022年＋

1.	Seo Y, Tamari K, Takahashi Y, Minami K, Tatekawa S, Isohashi F, Suzuki O, Akino Y, Ogawa K. Poly (ADP-ribose) polymerase inhibitors sensitize cancer cells to hypofractionated radiotherapy through altered selection of DNA double-strand break repair pathways. Int J Radiat Biol. 2022;98(7):1222-1234.
2.	Yagi M, Takahashi Y (Equal contribution), Minami K, Matsuura T, Nam JM, Onodera Y, Akagi T, Maeda T, Okimoto T, Shirato H, Ogawa K. A Consistent Protocol Reveals a Large Heterogeneity in the Biological Effectiveness of Proton and Carbon-Ion Beams for Various Sarcoma and Normal-Tissue-Derived Cell Lines. Cancers (Basel). 2022;14(8):2009.
3.	Misaki S, Murata S, Shimoji M, Iwai T, Sihombing AM, Aoki K, Takahashi Y, Yoshiyuki Watanabe. Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor. Jpn J Radiol 2022;40(12):1307-1315.
4.	Katsuki S, Takahashi Y (Corresponding author), Tamari K, Minami K, Takenaka W, Ibuki Y, Yamamoto J, Tatekawa S, Hayashi K, Seo Y, Isohashi F, Ogawa K, Koizumi M. Radiation therapy enhances systemic antitumor efficacy in PD-L1 therapy regardless of sequence of radiation in murine osteosarcoma. PLOS ONE 2022;17(7):e0271205-e0271205.
5.	Yamamoto J, Takahashi Y (Corresponding author), Minami K, Tamari K, Katsuki S, Takenaka W, Tatekawa S, Hayashi K, Seo Y, Isohashi F, Ogawa K, Koizumi M. High Dose Local Photon Irradiation Is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance the Abscopal Response in a Murine Pancreatic Carcinoma Model. Cancers 2022;14(9):2087.
6.	矢野恒夫、角永悠一郎、樺山一哉、加藤弘樹、高橋豊、山村朝雄、長谷川功紀、佐藤達彦、渕上剛志、渡部直史、巽光朗、平林容子、藤井博史、米倉義晴、深瀬浩一. アルファ線核医学治療のための薬剤開発の考察（その７）－足元を固めながらナノメディシンTATの実用化を目指して－（後編）PHARM TECH JAPAN 2022;38(2):281-289.
7.	矢野恒夫、角永悠一郎、樺山一哉、加藤弘樹、高橋豊、山村朝雄、長谷川功紀、佐藤達彦、渕上剛志、渡部直史、巽光朗、平林容子、藤井博史、米倉義晴、深瀬浩一. アルファ線核医学治療のための薬剤開発の考察（その７）－足元を固めながらナノメディシンTATの実用化を目指して－（前編）PHARM TECH JAPAN 2022;38(1):281-289.

2021年＋

1.	Ibuki Y, Takahashi Y (Corresponding author), Tamari K, Minami K, Seo Y, Isohashi F, Koizumi M, Ogawa K. Local hyperthermia combined with CTLA-4 blockade induces both local and abscopal effects in a murine breast cancer model. Int J Hyperthermia. 2021;38(1):363-371.
2.	Adachi T, Zhao W, Minami K, Yokoyama Y, Okuzaki D, Kondo R, Takahashi Y, Tamari K, Seo Y, Isohashi F, Yamamoto H, Koizumi M, Ogawa K. Chk1 suppression leads to a reduction in the enhanced radiation-induced invasive capability on breast cancer cells. J Radiat Res. 2021;62(5):764-772.
3.	高橋豊. ステージIVのがんに打ち勝つ放射線治療の確立を目指した生物研究. 放射線治療かたろう会学誌 2021;26:51-55.
4.	高橋豊. 基礎的観点からみた腫瘍免疫に対する放射線治療の役割. JASTRO NEWSLETTER 2021;138:22-24.

2020年＋

1.	Takenaka W, Takahashi Y (Corresponding author), Tamari K, Minami K, Katsuki S, Seo Y, Isohashi F, Koizumi M, Ogawa K. Radiation Dose Escalation Is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma. Cancers 2020;12(6):E1546
2.	Li Z, Tamari K, Seo Y, Minami K, Takahashi Y, Tatekawa S, Otani K, Suzuki O, Isohashi F, Ogawa K. Dydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening. Radiother Oncol 2020;148:21-29.
3.	Seo Y, Tamari K, Takahashi Y, Minami K, Isohashi F, Suzuki O, Sumida I, Ogawa K. Impact of accumulated alterations in driver and passenger genes on response to radiation therapy. Br J Radiol 2020;93(1109):20190625.
4.	小川和彦、高橋豊、皆巳和賢、玉利慶介、礒橋文明. 【放射線治療の現状と将来】放射線治療と新規薬剤との併用. Medical Science Digest 2020;46(13): 796-799.
5.	皆巳和賢、高橋豊、玉利慶介、瀬尾雄二、礒橋文明、小川和彦. 放射線のがん転移能に与える影響Effect of radiation on the metastatic potential in cancer. 放射線生物研究 Radiation Biology Research Communications 2020;55 (3):264-277.

2019年＋

1.	Zuro D, Vagge S, Broggi S, Agostinelli S, Takahashi Y, Brooks J, Leszcynska P, Liu A, Zucchetti C, Saldi S, Han C, Cattaneo M, Giebel S, Mahe MA, Sanchez JF, Alaei P, Anna C, Dusenbery K, Pierini A, Storme G, Aristei C, Wong JYC, Hui S.Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation. Radiother Oncol. 2019;141:275-282.
2.	Tamari K, Sano K, Li Z, Seo Y, Otani K, Tatekawa S, Toratani M, Takaoka Y, Takahashi Y, Minami K, Isohashi F, Koizumi M, Ogawa K.Ro 90-7501 Is a Novel Radiosensitizer for Cervical Cancer Cells that Inhibits ATM Phosphorylation. Anticancer Res. 2019;39(9):4805-4810.
3.	Takahashi Y, Yasui T, Minami K, Tamari K, Otani K, Isohashi F, Seo Y, Koizumi M, Ogawa K. Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma. Oncotarget 2019;10(6):633-646.

2018年＋

1.	Ohtani Y, Shimamoto S, Sumida I, Takahashi Y, Tani S, Ogawa K, Shimamoto K. Impact of different Ir-192 source models on dose calculations in high-dose-rate brachytherapy. Physics and Imaging in Radiation Oncology 2018;7:23-26.
2.	Nakano H, MinamiK, Yagi M, Imaizumi H, Otani Y, Inoue S, Takashina M, Seo Y, Takahashi Y, Sumida I, Ogawa K, Koizumi M. Radiobiological effects of flattening filter-free photon beams on A549 non-small-cell lung cancers. J Radiat Res 2018,;59(4):442-445.
3.	Tanaka K, Kajimoto T, Hayashi T, Asanuma O, Hori M, Kamo KI, Sumida I, Takahashi Y, Tateoka K, Bengua G, Sakata K, Endo S. An in vitro verification of strength estimation for moving an 125-I source during implantation in brchytherapy. J Radiat Res 2018;59(4):484-489.

2017年＋

1.	Takahashi Y, Yasui T, Tamari K, Minami K, Otani K, Isohashi F, Seo Y, Kambe R, Koizumi M, Ogawa K. Radiation enhanced the local and distant antitumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma. PLoS One 2017;12(12):e0189697.
2.	Takahashi Y, Yasui T, Minami K, Tamari K, Otani K, Seo Y, Isohashi F, Koizumi M, Ogawa K. Radiation enhances the efficacy of antitumor immunotherapy with an immunocomplex of Interleukin-2 and its monoclonal antibody. Anticancer Res 2017;37:6799-6806.
3.	Magome T, Froelich J, Holtan SG, Takahashi Y, Verneris MR, Brown K, Dusenbery K, Wong J, Hui SK. Whole-Body distribution of leukemia and functional total marrow irradiation based on FLT-PET and Dual-Energy CT. Molecular Imaging 2017;16:1-6.
4.	Hui S, Takahashi Y, Holtan SG, Azimi R, Seelig D, Yagi M, Ingvalson J, Alaei P, Sharkey L, Kodal B, Peterson N, Meyer C, Godin L, Ehrhardt M, Storme G, Zhou D, Panoskaltsis-Mortari A. Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents. Radiother Oncol 2017;124(3):468-474.
5.	Kaveh K, Takahashi Y, Farrar MA, Storme G, Guido M, Piepenburg J, Penning J, Foo J, Leder KZ, Hui SK. Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistance. PLoS Computational Biology 2017;13(7);e1005482.
6.	Hui S, Brunstein C, Takahashi Y, DeFor T, Holtan SG, Bachanova V, Wilke C, Zuro D, Ustun C, Weisdorf D, Dusenbery K, Verneris MR. Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2017;23(7):1110-1116.
6.	Hamatani N, Sumida I, Takahashi Y, Oda M, Seo Y, Isohashi F, Tamari K, Ogawa K. Three-dimensional dose prediction and validation with the radiobiological gamma index based on a relative seriality model for head-and-neck IMRT. J Radiat Res 2017;58(5):701-709.
7.	Arentsen L, Hansen KE, Yagi M, Takahashi Y, Shanley R, McArthur A, Bolan P, Magome T, Yee D, Froelich J, Hui SK. Use of dual energy computed tomography to measure skeletal-wide marrow composition and cencellous bone mineral density. J Bone Miner Metab 2017;35(4):428-436.

2016年＋

1.	Otani K, Naito Y, Sakaguchi Y, Seo Y, Takahashi Y, Kikuta J, Ogawa K, Ishii M. Cell-cycle-controlled radiation therapy was effective for treating a murine malignant melanoma cell line in vitro and in vivo. Sci Rep. 2016;6:30689.
2.	Magome T, Haga A, Takahashi Y, Nakagawa K, Dusenbery KE, Hui SK. Fast MVCT: A rapid imaging method for total body or marrow irradiation in helical tomotherapy. Int J Radiat Oncol Biol Phys. 2016;96(3):688-695.
3.	Magome T, Froelich J, Takahashi Y, Arentsen L, Holtan S, Brown K, Haga A, Nakagawa K, Chakrabarty JL, Giebel S, Wong J. Evaluation of functional marrow irradiation based on skeletal marrow composition obtained using dual-energy CT. Int J Radiat Oncol Biol Phys 2016;96(3):679-687.
4.	Anetai Y, Sumida I, Takahashi Y, Yagi M, Mizuno H, Ota S, Suzuki O, Tamari K, Seo Y, Ogawa K. A concept for classification of optimal breathing pattern for use in radiotherapy tracking, based on respiratory tumor kinematics and minimum jerk analysis. Med phys 2016;43(6):3168-3177
5.	Seo Y, Tamari K, Yoshioka Y, Isohashi F, Suzuki O, Hayashi K, Takahashi Y, Baek S, Otani K, Ogawa K.Characterization of in vitro radiosensitization in mammalian cells using biomathematical modelling: implications for hypofractionated radiotherapy with a combined modality approach. Br J Radiol. 2016;89:20150724
6.	Seo Y, Tamari K, Yoshioka Y, Isohashi F, Suzuki O, Hayashi K, Takahashi Y, Baek S, Otani K, Ogawa K.Characterization of in vitro radiosensitization in mammalian cells using biomathematical modelling: implications for hypofractionated radiotherapy with a combined modality approach. Br J Radiol. 2016;89:20150724
7.	高橋豊、玉利慶介、瀬尾雄二、小川和彦. 化学療法・分子標的薬との併用治療の動向. Current Therapy 2016;34 (5):68-74.

2015年＋

1.	Arentsen L, Yagi M, Takahashi Y, Bolan PJ, White M, Yee D, Hui S. Validation of marrow fat assessment using noninvasive imaging with histologic examination of human bone samples. Bone. 2015;72:118-22.
2.	Maruoka S, Yoshioka Y, Isohashi F, Suzuki O, Seo Y, Otani Y, Akino Y, Takahashi Y, Sumida I, Ogawa K. Correlation between patients' anatomical characteristics and interfractional internal prostate motion during intensity modulated radiation therapy for prostate cancer. SpringerPlus. 2015;4:579.
3.	Anetai Y, Sumida I, Takahashi Y, Yagi M, Ota S, Mizuno H, Ogawa K. Reference respiratory waveforms by minimum jerk model analysis. Med phys. 2015;42(9): 5066-5074.
4.	Hui SK, Arentsen L, Sueblinvong T, Brown K, Bolan P, Ghebre RG, Downs L, Shanley R, Hansen KE, Minenko AG, Takahashi Y, Yagi M, Zhang Y, Geller M, Reynolds M, Lee CK, Blaes AH, Allen S, Zobel BB, Le C, Froelich J, Rosen C, Yee D. A phase I feasibility study of multi-modality imaging assessing rapid expansion of marrow fat and decreased bone mineral density in cancer patients. Bone. 2015; 73:90-7.
5.	Arentsen L, Yagi M, Takahashi Y, Bolan PJ, White M, Yee D, Hui S. Validation of marrow fat assessment using noninvasive imaging with histologic examination of human bone samples. Bone. 2015;72:118-22.
6.	Islam MS, Stemig ME, Takahashi Y, Hui SK. Radiation response of mesenchymal stem cells derived from bone marrow and human pluripotent stem cells. J Radiat Res. 2015;56(2):269-77.
7.	Takahashi Y, Vagge S, Agostinelli S, Han E, Matulewicz L, Schubert K, Chityala R, Ratanatharathorn V, Tournel K, Penagaricano JA, Florian S, Mahe MA, Verneris MR, Weisdorf DJ, Corvo R, Dusenbery KE, Storme G, Hui SK. Multi-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiation. Int J Radiat Oncol Biol Phys.2015;91(1):30-8.
8.	高橋豊. 造血器腫瘍に対する高精度放射線治療の利用―医学物理学と生物学の接点の探求―RADFAN 2015;13 (14);98-100.

2014年＋

1.	Takahashi Y, Hui SK. Fast, simple, and informative patient-specific dose verification method for intensity modulated total marrow irradiation with helical tomotherapy. Radiat Oncol. 2014;9:34.
2.	Morimoto M, Yoshioka Y, Konishi K, Isohashi F, Takahashi Y, Ogata T, Koizumi M, Teshima T, Bijl HP, van der Schaaf A, Langendijk JA, Ogawa K. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy. Tumori. 2014;100(3):265-71.

1.

Takahashi Y, Hui SK. Fast, simple, and informative patient-specific dose verification method for intensity modulated total marrow irradiation with helical tomotherapy. Radiat Oncol. 2014;9:34.

2.

Morimoto M, Yoshioka Y, Konishi K, Isohashi F, Takahashi Y, Ogata T, Koizumi M, Teshima T, Bijl HP, van der Schaaf A, Langendijk JA, Ogawa K. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy. Tumori. 2014;100(3):265-71.

2013年＋

1.	Takahashi Y, Verneris MR, Dusenbery KE, Wilke CT, Storme G, Weisdorf DJ, Hui SK. Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy. Int J Radiat Oncol Biol Phys. 2013; 87(4):832-9.
2.	Akino Y, Yoshioka Y, Fukuda S, Maruoka S, Takahashi Y, Yagi M, Mizuno H, Isohashi F, Ogawa K. Estimation of rectal dose using daily megavoltage cone-beam computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys. 2013;87(3):602-8.
3.	Takahashi Y, Hui SK. Impact of very long time output variation in the treatment of total marrow irradiation with helical tomotherapy. Radiat Oncol. 2013;20;8:123.
4.	Isohashi F, Yoshioka Y, Mabuchi S, Konishi K, Koizumi M, Takahashi Y, Ogata T, Maruoka S, Kimura T, Ogawa K. Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer. Int J Radiat Oncol Biol Phys. 2013;85(3):728-34.
5.	Yagi M, Ueguchi T, Koizumi M, Ogata T, Yamada S, Takahashi Y, Sumida I, Akino Y, Konishi K, Isohashi F, Tomiyama N, Yoshioka Y, Ogawa K. Gemstone spectral imaging: determination of CT to ED conversion curves for radiotherapy treatment planning. J Appl Clin Med Phys. 2013;14(5):173-86.

2012年＋

1.	Takahashi Y, Koizumi M, Sumida I, Isohashi F, Ogata T, Akino Y, Yoshioka Y, Maruoka S, Inoue S, Konishi K, Ogawa K. The usefulness of an independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix. J Radiat Res. 2012;53(6):936-44.
2.	Mizuno H, Takahashi Y, Tanaka A, Hirayama T, Yamaguchi T, Katou H, Takahara K, Okamoto Y, Teshima T. Homogeneity of GAFCHROMIC EBT2 film among different lot numbers. J Appl Clin Med Phys. 2012;13(4):3763.
3.	Sumida I, Yamaguchi H, Kizaki H, Koizumi M, Ogata T, Takahashi Y, Yoshioka Y. Quality assurance of MLC leaf position accuracy and relative dose effect at the MLC abutment region using an electronic portal imaging device. J Radiat Res. 2012;53(5):798-806.
4.	Satoh T, Yamanaka H, Yamashita T, Aoki M, Egawa S, Saito S, Sakata S, Shibuya H, Sugiura N, Takahashi Y, Nishimura T, Hamada T, Miki T, Yorozu A, Dokiya T. Deaths within 12 months after (125)I implantation for brachytherapy of prostate cancer: an investigation of radiation safety issues in Japan (2003-2010), Brachytherapy. 2012;11(3):192-6.
5.	Akino Y, Koizumi M, Sumida I, Takahashi Y, Ogata T, Ota S, Isohashi F, Konishi K, Yoshioka Y. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82(5):1715-22.
6.	高橋豊. 患者に説明できる！がんと放射線の知識－放射線って何だろう－. がん看護 2012;17(3):383-387.

2011年＋

1.	Ogata T, Koizumi M, Sumida I, Takahashi Y, Akino Y, Isohashi F, Konishi K, Yoshioka Y, Inoue T. Weekly verification of dosimetric data for virtual wedge using a 2D diode detector array. Med Dosim. 2011;36(3):246-9.
2.	Mizuno H, Okamoto H, Fukuoka M, Hanyu Y, Kurooka M, Kohno R, Nishio T, Kumazaki Y, Tachibana H, Takahashi Y, Mori S, Masai N, Sasaki K. Multi-institutional retrospective analysis of the inhomogeneity correction for radiation therapy of lung cancer. J Radiat Res. 2011;52(1):69-74.
3.	Yoshioka Y, Konishi K, Sumida I, Takahashi Y, Isohashi F, Ogata T, Koizumi M, Yamazaki H, Nonomura N, Okuyama A, Inoue T. Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions. Int J Radiat Oncol Biol Phys. 2011;80(2):469-75.
4.	水野秀之、五十川裕之、岡本裕之、亀岡覚、熊崎祐、黒岡将彦、河野良介、佐々木浩二、高橋豊、橘英伸、西尾禎治、宮岸朋子、羽生裕二、正岡範尚、峰村俊行、森慎一郎. X 線線量計算の不均質補正法に関する医学物理ガイドライン日本医学物理学会タスクグループ02. 医学物理 2011;31 (Sup.5): 73-94.
5.	礒橋文明、吉岡靖生、小西浩司、隅田伊織、高橋豊、尾方俊至、小泉雅彦、井上武宏、馬淵誠士、榎本隆之、木村正: 婦人科領域における放射線腫瘍学の進歩　さらなる治療成績の向上にむけて－子宮頸癌に対する高線量率組織内照射. 日本婦人科腫瘍学会雑誌 2011;29(2):195-199.

2010年＋

1.	Takahashi Y, Koizumi M, Sumida I, Ogata T, Akino Y, Yoshioka Y, Konishi K, Isohashi F, Ota S, Inoue T. What is the optimum minimum segment size used in step and shoot IMRT for prostate cancer? J Radiat Res. 2010;51(5):543-52.
2.	Isohashi F, Yoshioka Y, Koizumi M, Suzuki O, Konishi K, Sumida I, Takahashi Y, Ogata T, Kotsuma T, Inoue T. Rectal dose and source strength of the high-dose-rate iridium-192 both affect late rectal bleeding after intracavitary radiation therapy for uterine cervical carcinoma. Int J Radiat Oncol Biol Phys. 2010;77(3):758-64.
3.	高橋豊、北野崇夫、中田陵賀、野里健司、萩村恵理子、藤井和彦、松尾雅基、山本周平、池田恢. より正確なDosimetryへ向けて－市立堺病院における治療計画装置の高精度線量計算　法とわが国の標準吸収線量測定法の導入－.市立堺病院医学雑誌2010;13:13-24.
4.	池田恢、新保宗史、福村明史、黒澤忠弘、峯村俊行、高橋豊、山田崇裕、川村慎二：第97回日本医学物理学会学術大会シンポジウム「線量校正と標準測定法の動向」のまとめ. 医学物理 2010;29(3):57-86.

2009年＋

1.	Sumida I, Koizumi M, Takahashi Y, Ogata T, Akino Y, Isohashi F, Konishi K, Yoshioka Y, Inoue T. Verification of air-kerma strength of 125I seed for permanent prostate implants in Japan. Int J Clin Oncol. 2009;14(6):525-8.
2.	Isohashi F, Yoshioka Y, Koizumi M, Konishi K, Sumida I, Takahashi Y, Ogata T, Morishige KI, Enomoto T, Kawaguchi Y, Kotsuma T, Adachi K, Fukuda S, Akino Y, Inoue T. High-dose-rate interstitial brachytherapy for previously untreated cervical carcinoma. Brachytherapy. 2009;8(2):234-239.
3.	尾方俊至、手島昭樹、高橋豊、古澤佳也、松浦成昭、光子線と重粒子線によるがんの転移過程と血管新生に及ぼす影響. 放射線生物研究2009;44(2):199-207.

2008年＋

1.	Nose T, Koizumi M, Yoshida K, Nishiyama K, Sasaki J, Ohnishi T, Kozuka T, Gomi K, Oguchi M, Sumida I, Takahashi Y, Ito A, Yamashita T. In vivo dosimetry of high-dose-rate interstitial brachytherapy in the pelvic region: use of a radiophotoluminescence glass dosimeter for measurement of 1004 points in 66 patients with pelvic malignancy. Int J Radiat Oncol Biol Phys. 2008;70(2):626-33.
2.	Yamashita T, Nose T, Takahashi Y. History of Japan's radioactive sources for brachytherapy. Brachytherapy 2008;7(2):165-166.

2007年＋

1.	大沢敦, 橋本竹雄, 吉野慎一, 木村雅春, 伊藤照生, 中島大, 五月女達子, 大友結子, 高橋豊, 佐藤智春, 倉本秋夫. 同室設置型CT/X-ray simulatorにおける共通治療寝台のたわみ測定－実際の照射部位と体重心を模した患者モデルを想定して－. 日放腫学誌2007;19 (1): 49-54.
2.	西尾禎治、河野良介、森慎一郎、水野秀之、羽生裕二、高橋豊. X 線治療計画システムに関する QA ガイドライン　日本医学物理学会タスクグループ０１医学物理 2007;24 (Sup.4):51-78
3.	高橋豊、橘英伸、小塚拓洋、山下孝. 前立腺癌I-125永久挿入治療後の外部照射時のシードによる線量分布擾乱の検討. INNERVISION 2007; 22 (7).
4.	高橋豊. がんの放射線治療の最前線「放射線治療の進め方－治療計画を中心に」.ナース専科2007;8:100-103.

2006年＋

1.	Takahashi Y, Ito A, Sumida I, Kozuka T, Gomi K, Nose T, Ito T, Yamashita T. Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy. Radiat Med. 2006;24(10):675-9.
2.	Nose T, Komoike Y, Yoshida K, Koizumi M, Motomura K, Kasugai T, Inaji H, Nishiyama K, Koyama H, Kozuka T, Gomi K, Oguchi M, Takahashi Y, Sumida I, Yamashita T. A pilot study of wider use of accelerated partial Breast irradiation: Intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy. Breast Cancer 2006;13(3):289-299.
3.	Takahashi Y, Ito A, Sumida I, Kozuka T, Gomi K, Nose T, Ito T, Yamashita T. Preliminary study of correction of originalmetal artifacts due to I-125 seeds in postimplant dosimetry for prostate permanent implant brachytherapy. Radiat Med. 2006;24(2):6133-8. (IF=1.1、引用数13)
4.	Onishi H, Takahashi Y, Nakamura K, Shikama N, Kodaira T, Toita T, Yamauchi C, Mistumori H, Kenjyo M, Koizumi M, Sumi M, Uno T, Ashino Y, Teshima T, Ogawa K. Radiation Oncology in Multidisciplinary Cancer Therapy. 2006; 11-24, 60-65.
5.	手島昭樹、立崎英夫、光森通英、三橋紀夫、宇野隆、中村和正、角美奈子、鹿間直人、戸板孝文、小口正彦、権丈雅浩、小泉雅彦、大西洋、高橋豊、古平毅、山内智香子、芦野靖夫、小川和彦、井上俊彦. JASTRO平成15・16年度研究課題報告医療実態調査研究による放射線治療施設構造基準化（案）の改訂（日本版ブルーブック）J Jpn Soc Ther Radiol Oncol 2006;18:107-112.
6.	高橋豊、手島昭樹、尾方俊至、松浦成昭. 放射線の血管新生に対する抑制効果. 乳癌の臨床 2006;21(6):523-529.
7.	山下孝、小口正彦、能勢隆之、五味光太郎、小塚拓洋、熊田まどか、田原誉敏、大城佳子、高橋豊. 乳癌－放射線療法の今昔. 乳癌の臨床 2006;20(6):547-555.

2005年＋

1.	Ogata T, Teshima T, Kagawa K, Hishikawa Y, Takahashi Y, Kawaguchi A, Suzumoto Y, Nojima K, Furusawa Y, Matsuura N. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res. 2005;65(1):113-20.
2.	Takahashi Y, Kozuka T, Gomi K, Tahara T, Yonese J, Okubo Y, Fukui I, Yamashita T. I-125 permanent implant brachytherapy. Jpn J Med Phys 2005; 25 (supp. 3-1):32-35.
3.	福村明史、遠藤真広、金井達明、竹下美津恵、坂間誠、伊藤彬、高橋豊、保科正夫、草野陽介、高瀬英輔、Jayantha Gunaratne. 平行平板形電離箱（ルース型およびアドバンスト・マーカス型）の校正定数比の実験的評価. 医学物理 2005;25 (2):75-79.

2004年＋

1.	Nakamura K, Teshima T, Takahashi Y, Imai A, Koizumi M, Mitsuhashi N, Shioyama Y, Inoue T; Japanese PCS Working Subgroup of Prostate Cancer. Radiotherapy for localized hormone-refractory prostate cancer in Japan. Anticancer Res. 2004;24(5B):3141-5.
2.	Toita T, Mitsuhashi N, Teshima T, Maebayashi K, Nakamura K, Takahashi Y, Inoue T; Japanese PCS Working Subgroup for Uterine Cervical Cancer. Postoperative radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan. Jpn J Clin Oncol. 2004;34(2):99-103.
3.	Takahashi Y, Ito A, Yamashita T. Verification of accuracy of dose calculation of RTP systems of high dose rate brachytherapy by Monte Carlo Simulation. Proc EGS4 Meeting, 2004;74-80.
4.	高橋豊、手島昭樹、河口直正、浜田吉之輔、真館亜矢子、尾方俊至、池田聡子、水野裕一、野島久美恵、古澤佳也、松浦成昭. 粒子線による遠隔転移制御の可能性－血管新生に対する抑制効果－. 癌の臨床 2004; 50 (13):1107-1111.
5.	高橋豊、山下孝. I-125シード線源永久挿入療法による前立腺癌治療. RADIOISOTOPES 2004;53 (12): 645-655.
6.	高橋豊. 前立腺癌に対するI-125シード線源永久刺入治療について. 医学物理 2004;24(Sup.4):51-78.

2003年＋

1.	Gomi K, Oguchi M, Hirokawa Y, Kenjo M, Ogata T, Takahashi Y, Nakamura N, Yamashita T, Teshima T, Inoue T; Japanese Patterns of Care Study Working Subgroup of Esophageal Cancer. Process and preliminary outcome of a patterns-of-care study of esophageal cancer in Japan: patients treated with surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56(3):813-22.
2.	Takahashi Y, Teshima T, Kawaguchi N, Hamada Y, Mori S, Madachi A, Ikeda S, Mizuno H, Ogata T, Nojima K, Furusawa Y, Matsuura N. Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res. 2003;63(14):4253-7.
3.	Sugiyama H, Teshima T, Ohno Y, Inoue T, Takahashi Y, Oshima A, Sumi M, Uno T, Ikeda H; Japanese PCS Working Subgroup for Lung Cancer. The Patterns of Care Study and Regional Cancer Registry for non-small-cell lung cancer in Japan. Int J Radiat Oncol Biol Phys. 2003;56(4):1005-12.
4.	Nakamura K, Teshima T, Takahashi Y, Imai A, Koizumi M, Mitsuhashi N, Inoue T; Japanese PCS Working Subgroup of Prostate Cancer. Radical radiation therapy for prostate cancer in Japan: a Patterns of Care Study report. Jpn J Clin Oncol. 2003;33(3):122-6.

2002年＋

1.	中村和正, 手島昭樹, 高橋豊,今井敦,小泉雅彦, ,三橋紀夫,井上俊彦, 日本PCS前立腺癌小作業部会: EBMとPCSからみた臓器別放射線治療法―前立腺癌―.日放腫会誌2002;14:79-85.
2.	中村和正, 手島昭樹, 高橋豊,今井敦,小泉雅彦, ,三橋紀夫,井上俊彦:１．わが国での医療実態調査研究による前立腺癌根治的外部照射の現状.―コンフォーマル照射の有無による治療成績の検討―. 泌尿器外科2002;15(8):849-852.
3.	高橋豊、手島昭樹、東山繁樹、池田聡子、水野裕一、尾方俊至、松浦成昭：放射線によるTGF-αのsheddingをターゲットとした増感効果. 癌の臨床 2002;48(6):341-344.

2001年＋

1.	杉山裕美、大野ゆう子、手島昭樹、高橋豊、井上俊彦、角美奈子、池田恢、宇野隆、日本PCS肺がん小作業部会. ＰＣＳと大阪府地域がん登録データの比較. 癌の臨床　2001;47(8): 637-642.
2.	戸板孝文、三橋紀夫、前林勝也、小川和彦、高橋豊、手島昭樹、井上俊彦、日本PCS子宮頚癌小作業部会. PCSによる子宮頸癌の手術例に対する放射線治療の現状. 癌の臨床 2001, 47(8), 675-680.
3.	中村和正、手島昭樹、高橋豊、今井敦、小泉雅彦、能勢隆之、三橋紀夫、井上俊彦、日本PCS前立腺癌小作業部会. PCSによる前立腺癌に対する放射線治療の現状. 癌の臨床 2001;47(8):693-699.
4.	五味光太郎、小口正彦、山下孝、中村直樹、権丈雅浩、廣川裕、尾方俊至、高橋豊、手島昭樹、井上俊彦、日本PCS食道癌小作業部会. PCSによる食道癌の手術例に対する放射線治療の現状. 癌の臨床2001;47(8):663-668.
5.	小泉雅彦、中村和正、今井敦、能勢隆之、井上俊彦、手島昭樹、高橋豊、日本PCS前立腺癌小作業部会. PCSによるわが国における小線源治療の現状. 癌の臨床 2001;7(8): 701-709.

大阪大学大学院医学系研究科生体医用物理工学講座放射線治療生物学研究室

論文＋